Friday, October 2, 2026

OpenAI Pushes Fully Automated AI Researchers as Enterprise Infrastructure Spend Accelerates

OpenAI's chief scientist says AI models are nearing the ability to work indefinitely without human help, pursuing fully automated research labs housed in data centers. The development coincides with enterprise AI infrastructure deals and corporate AI acquisitions, despite market indices dropping 1.4-1.6% amid investor uncertainty about AI monetization timelines.

LM Salvado
LM Salvado

March 24, 2026

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
OpenAI Pushes Fully Automated AI Researchers as Enterprise Infrastructure Spend Accelerates
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

OpenAI is pursuing AI models capable of functioning as fully automated researchers, according to chief scientist Jakub Pachocki. "I think we are getting close to a point where we'll have models capable of working indefinitely in a coherent way just like people do," Pachocki stated.

Pachocki projects a future where "you kind of have a whole research lab in a data center," as improvements in model capability enable extended autonomous operation without human intervention. The shift stems from capability gains that allow models to work longer periods independently, moving AI from tool to autonomous agent.

The vision requires containing powerful systems in isolated environments. Pachocki argues very powerful models should be "deployed in sandboxes cut off from anything they could break or use to cause harm." He acknowledged regulatory challenges: "I think this is a big challenge for governments to figure out."

The automated research push occurs alongside enterprise AI infrastructure buildout. Nvidia has partnered with Nebius to expand cloud AI infrastructure, while S&P Global acquired Enertel to strengthen AI capabilities. These deals reflect corporate technology spending shifts toward AI infrastructure and acquisitions.

Market reaction suggests investor caution about AI monetization speed. Major indices fell 1.4-1.6% despite aggressive infrastructure investment, occurring as the Federal Reserve maintains current interest rates. The gap between infrastructure spending and revenue realization creates valuation uncertainty for AI-focused companies.

The convergence of autonomous AI research capabilities and enterprise infrastructure investment marks a maturation phase for artificial intelligence deployment. Companies are building the computational foundation for AI systems while researchers push toward autonomous operation, concentrating technological capacity in fewer hands.

Corporate AI acquisitions target domain expertise rather than raw computing power. S&P Global's Enertel purchase exemplifies this pattern, adding specialized AI capabilities to existing platforms rather than building from scratch.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleMIT Technology Review
    OpenAI is throwing everything into building a fully automated researcher
  2. [2]News articleYahoo Finance· January 22, 2026
    4 Medical Supply Stocks Poised to Gain in a Prospering Industry
  3. [3]News articleYahoo Finance· February 24, 2026
    Agentic AI Foundation Welcomes 97 New Members As Demand for Open, Collaborative Agent Standardization Increases
  4. [4]Press releaseGlobeNewswire· March 13, 2026
    Agero Enters into Agreement to Acquire Urgently, for $5.50 in Cash Per Share, Expanding Tech-Driven Roadside Assistance Across Automotive, Fleet, Rental, and Insurance Markets
  5. [5]News articleYahoo Finance· November 26, 2025
    AI to Reshape the Global Technology Landscape in 2026, Says TrendForce
  6. [6]News articleMIT Technology Review
    Can quantum computers now solve health care problems? We’ll soon find out.
  7. [7]News articleYahoo Finance· January 30, 2026
    Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility
  8. [8]News articleYahoo Finance· March 19, 2026
    Morning Brief: 3 big questions, 2 answers, and rate cut hopes remain alive
  9. [9]News articleYahoo Finance· March 17, 2026
    Nebius Teams With NVIDIA to Build Cloud for Robotics and Physical AI
  10. [10]News articleYahoo Finance· March 18, 2026
    S&P Global Acquires Enertel AI Corporation to Enhance Power Market Offering
  11. [11]News articleCrunchbase News
    The Rising Investors Behind The New Unicorn Class
  12. [12]Press releaseGlobeNewswire· March 19, 2026
    Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com